Statin use linked with better outcomes in patients starting ADT for prostate cancer

Video

“We continue to see a building story of benefit of statin medications in men who have prostate cancer,” says Robert J. Hamilton, MD, MPH.

In this interview, Robert J. Hamilton, MD, MPH, discusses findings from a recent study published in European Urology titled, “The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy,” for which he served as a study author. Hamilton is an associate professor of urology at the University of Toronto.

More videos:

Clinical care pathway demonstrates efficacy for patients with overactive bladder

Analysis underscores importance of pretreatment urine cultures in patients with recurrent UTI

A primer for urologists on statutes of limitations

Related Videos
Dr. Christopher Wallis in an interview with Urology Times
Randall A. Lee, MD, answers a question during a Zoom video interview
Edward M. Schaeffer, MD, PhD, answers a Zoom video interview question
Man talking with doctor | Image Credit: © Chinnapong - stock.adobe.com
James Ferguson III, MD, PhD, answers a question during a Zoom video interview
Nicholas L. Kavoussi, MD, answers a question during a Zoom video interview
Paul M. Yonover, MD, FACS, an expert on prostate cancer
Paul M. Yonover, MD, FACS, an expert on prostate cancer
Paul M. Yonover, MD, FACS, an expert on prostate cancer
© 2023 MJH Life Sciences

All rights reserved.